Question Everything. See who's reporting it.

FSSAI files cases against Nestle over infant formula Biotin shortfall

Source: Business Standard

The story in brief

FSSAI has filed three adjudication cases against Nestle India over three infant products found non-conforming with Biotin requirements under 2020 regulations. The regulator examined NAN Excella Pro Stage 1, Lactogen Pro 1, and a follow-up formula, with shares of Nestle India falling nearly 2% on the BSE.

4 outletsSee what the other 3 outlets said

NEWXFree on Android and iPhone. Open in NEWX